Structure-Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides

被引:68
|
作者
Wu, Wenyan [1 ]
Li, Rongti [1 ]
Malladi, Subbalakshmi S. [1 ]
Warshakoon, Hemamali J. [1 ]
Kimbrell, Matthew R. [1 ]
Amolins, Michael W. [1 ]
Ukani, Rehman [1 ]
Datta, Apurba [1 ]
David, Sunil A. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA
关键词
MACROPHAGE-ACTIVATING LIPOPEPTIDE-2; ESCHERICHIA-COLI LIPOPROTEIN; ADAPTIVE IMMUNE-RESPONSE; BACTERIAL-CELL WALLS; HIV-1 TAT PROTEIN; LIPOTEICHOIC ACID; INNATE IMMUNITY; STAPHYLOCOCCUS-AUREUS; MYCOPLASMA-FERMENTANS; PEPTIDOGLYCAN;
D O I
10.1021/jm901839g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The N-termini of bacterial lipoproteins are acylated with a (S)-(2,3-bisacyloxypropyl)cysteinyl residue. Lipopeptides derived from lipoproteins activate innate immune responses by engaging Toll-like receptor 2 (TLR2) and are highly immunostimulatory and yet without apparent toxicity in animal models. The lipopeptides may therefore be useful as potential immunotherapeutic agents. Previous structure activity relationships in such lipopeptides have largely been obtained using murine cells, and it is now clear that significant species-specific differences exist between human and murine TLR responses. We have examined in detail the role of the highly conserved Cys residue as well as the geometry and stereochemistry of the Cys-Ser dipeptide unit. (R)-Diacylthioglycerol analogues are maximally active in reporter gene assays using human TLR2. The Cys-Ser dipeptide unit represents the minimal part-structure, but its stereochemistry was found not to be a critical determinant of activity. The thioether bridge between the diacyl and dipeptide units is crucial, and replacement by an oxoether bridge results in a dramatic decrease in activity.
引用
收藏
页码:3198 / 3213
页数:16
相关论文
共 50 条
  • [21] Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination
    Heuking, S.
    Iannitelli, A.
    Di Stefano, A.
    Borchard, G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 381 (02) : 97 - 105
  • [22] Toll-like receptor-2 exacerbates murine acute viral hepatitis
    Bleau, Christian
    Burnette, Melanie
    Filliol, Aveline
    Piquet-Pellorce, Claire
    Samson, Michel
    Lamontagne, Lucie
    IMMUNOLOGY, 2016, 149 (02) : 204 - 224
  • [23] Toll-like receptor-2 expression in normal and pathologic human placenta
    Rindsjo, Erika
    Holmlund, Ulrika
    Sverremark-Ekstrom, Eva
    Papadogiannakis, Nikos
    Scheynius, Annika
    HUMAN PATHOLOGY, 2007, 38 (03) : 468 - 473
  • [24] Toll-like receptor-2/6 stimulation promotes angiogenesis and reendothelialization
    Grote, K.
    Salguero, G.
    Sonnenschein, K.
    Grothusen, C.
    Muhlradt, P. F.
    Schieffer, B.
    EUROPEAN HEART JOURNAL, 2008, 29 : 240 - 240
  • [25] Toll-like receptor-2 expression in normal and pathologic human placenta
    Rindsjö, E.
    Holmlund, U.
    Sverremark-Ekstrom, E.
    Papadogiannakis, N.
    Scheynius, A.
    PLACENTA, 2006, 27 (9-10) : A42 - A42
  • [26] Toll-Like Receptor-2/-6 Stimulation Promotes Angiogenesis and Reendothelialization
    Grote, Karsten
    Salguero, Gustavo
    Grothusen, Christina
    Sonnenschein, Kristina
    Dittrich-Breiholz, Oliver
    Kracht, Michael
    Muhlradt, Peter
    Drexler, Helmut
    Schieffer, Bernhard
    CIRCULATION, 2008, 118 (18) : S449 - S449
  • [27] Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
    Kaushik, Deepender
    Kaur, Arshpreet
    Patil, Madhuri T.
    Sihag, Binita
    Piplani, Sakshi
    Sakala, Isaac
    Honda-Okubo, Yoshikazu
    Ramakrishnan, Saravanan
    Petrovsky, Nikolai
    Salunke, Deepak B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (10) : 8346 - 8360
  • [28] Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors
    Pollock, Julie A.
    Sharma, Naina
    Ippagunta, Sirish K.
    Redecke, Vanessa
    Haecker, Hans
    Katzenellenbogen, John A.
    CHEMMEDCHEM, 2018, 13 (20) : 2208 - 2216
  • [29] Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
    Morin, Matthew D.
    Wang, Ying
    Jones, Brian T.
    Su, Lijing
    Surakattula, Murali M. R. P.
    Berger, Michael
    Huang, Hua
    Beutler, Elliot K.
    Zhang, Hong
    Beutler, Bruce
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4812 - 4830
  • [30] Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection
    Darville, T
    O'Neill, JM
    Andrews, CW
    Nagarajan, UM
    Stahl, L
    Ojcius, DM
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 6187 - 6197